Medroxyprogesterone reverses tolerable dose metformin-induced inhibition of invasion via matrix metallopeptidase-9 and transforming growth factor-β1 in KLE endometrial cancer cells
D. H. Suh, S. Lee, H.-S. Park, N. H. Park
This study shows that medroxyprogesterone reverses metformin's anti-invasive effect in KLE endometrial cancer cells via MMP-9 and TGF-β1.
bioRxiv · Apr 2, 2019Cancer Biology